Joseph J Eron
University of North Carolina at Chapel Hill
H-index: 129
North America-United States
Top articles of Joseph J Eron
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Response to Drs. de Grooth and Parienti | The Journal of Infectious Diseases | Mark J Giganti Kara W Chew Joseph J Eron Davey M Smith Judith S Currier | 2024/2/7 |
HIV-1 envelope diversity and sensitivity to broadly neutralizing antibodies across stages of acute HIV-1 infection | AIDS | Laurie A VanderVeen Lisa Selzer Brian Moldt Aiyappa Parvangada Jiani Li | 2024/3/15 |
Safety of teropavimab and zinlirvimab with lenacapavir once every 6 months for HIV treatment: a phase 1b, randomised, proof-of-concept study | The Lancet HIV | Joseph J Eron Susan J Little Gordon Crofoot Paul Cook Peter J Ruane | 2024/3/1 |
Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody | PLoS pathogens | Tin Phan Carolin Zitzmann Kara W Chew Davey M Smith Eric S Daar | 2024/4/18 |
Sequence Analysis of Inducible, Replication-Competent Virus Reveals No Evidence of HIV-1 Evolution During Suppressive Antiviral Therapy Indicating A Lack Of Ongoing Viral … | Open Forum Infectious Diseases | Sook-Kyung Lee Amy Sondgeroth Yinyan Xu Joanna Warren Shuntai Zhou | 2024/4/17 |
Safety and Immune Responses Following Anti-PD-1 Monoclonal Antibody Infusions in Healthy Persons With Human Immunodeficiency Virus on Antiretroviral Therapy | Open Forum Infectious Diseases | Cynthia L Gay Ronald J Bosch Ashley McKhann Raymond Cha Gene D Morse | 2024/3 |
HIV Prevention Among Men Who Have Sex With Men: Tenofovir Alafenamide Combination Preexposure Prophylaxis Versus Placebo | The Journal of Infectious Diseases | Paul N Zivich Stephen R Cole Jessie K Edwards David V Glidden Moupali Das | 2024/4/15 |
COVID-19 hospitalization risk after outpatient nirmatrelvir/ritonavir use, January to August 2022, North Carolina | Journal of Antimicrobial Chemotherapy | Heather I Henderson David A Wohl William A Fischer Luther A Bartelt David van Duin | 2024/2/21 |
Persistence of a Skewed Repertoire of NK Cells in People with HIV-1 on Long-Term Antiretroviral Therapy | The Journal of Immunology | Renee R Anderko Allison E DePuyt Rhianna Bronson Arlene C Bullotta Evgenia Aga | 2024/3/29 |
The Effects of Human Immunodeficiency Virus Type 1 (HIV-1) Antigen-Expanded Specific T-Cell Therapy and Vorinostat on Persistent HIV-1 Infection in People With HIV on … | The Journal of Infectious Diseases | Cynthia L Gay Patrick J Hanley Shane D Falcinelli JoAnn D Kuruc Susan M Pedersen | 2024/2/13 |
Projected benefits of long-acting antiretroviral therapy in nonsuppressed people with human immunodeficiency virus experiencing adherence barriers | Open Forum Infectious Diseases | Wanyi Chen Monica Gandhi Paul E Sax Anne M Neilan Wendy H Garland | 2023/8 |
Sécurité et efficacité de Lenacapavir en association avec les bNAbs GS-5423 et GS-2872 administrés tous les 6 mois chez les personnes vivant avec le VIH | Médecine et Maladies Infectieuses Formation | J Eron S Little G Crofoot P Cook PJ Ruane | 2023/5/1 |
Pooling Different Placebos as a Control Group in a Randomized Platform Trial: Benefits and Challenges From Experience in the ACTIV-2 COVID-19 Trial | The Journal of Infectious Diseases | Carlee B Moser Kara W Chew Justin Ritz Matthew Newell Arzhang Cyrus Javan | 2023/9/1 |
Early antiretroviral therapy not associated with higher cryptococcal meningitis mortality in people with human immunodeficiency virus in high-income countries: an international … | Clinical Infectious Diseases | Suzanne M Ingle Jose M Miro Margaret T May Lauren E Cain Christine Schwimmer | 2023/7/1 |
The latency-reversing agent HODHBt synergizes with IL-15 to enhance cytotoxic function of HIV-specific T cells | JCI insight | Dennis C Copertino Jr Carissa S Holmberg Jared Weiler Adam R Ward J Natalie Howard | 2023/9/9 |
Greater Statin Interruption Rates and Lower Adherence for Women versus Men With HIV in the United States | Circulation | Thibaut Davy-Mendez Alan C Kinlaw Nwora Okeke Michelle Floris-Moore Joseph J Eron | 2023/11/7 |
Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and … | The Lancet HIV | Raphael J Landovitz Brett S Hanscom Meredith E Clement Ha V Tran Esper G Kallas | 2023/12/1 |
Publisher Correction: Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19 | nature communications | Kara W Chew Carlee Moser Eric S Daar David A Wohl Jonathan Z Li | 2023 |
Tixagevimab/Cilgavimab Im and Iv for Covid-19: A Randomized Controlled Activ-2 Trial | Topics in Antiviral Medicine | RA Bender Ignacio KW Chew C Moser JS Currier JJ Eron | 2023 |
Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2022 recommendations of the International Antiviral Society–USA panel | Jama | Rajesh T Gandhi Roger Bedimo Jennifer F Hoy Raphael J Landovitz Davey M Smith | 2023/1/3 |
